MS Health

MSI Australia, the Choice Fund and MS Health represent a nationwide reproductive health ecosystem, offering accredited services, the only safety net for underserviced populations, and a mission focused pharmaceutical sponsor.

MS Health is MSI Australia’s non-profit pharmaceutical wing, established with one goal in mind – to secure medical abortion access to all women and pregnant people in Australia.

MS Health led the introduction of Australia’s medical abortion medication into the Australian market and has sustained supply for over a decade.

As a profit-for-purpose provider, funds from MS Health are reinvested into the advocacy and infrastructure that maintains abortion access across Australia, including MSI Australia’s Choice Fund.

MSI Australia’s Choice Fund represents a national partnership for timely, compassionate access to abortion care, which provides access to women and pregnant people in Australia who would otherwise be unable to access critical reproductive care.

MS Health is Australia’s only non-profit pharmaceutical sponsor in the sexual and reproductive healthcare space – driven by purpose, not profit.

If you are a healthcare professional and would like to learn more about MS-2 Step® (mifepristone, misoprostol) or Mifepristone Linepharma® 200 mg Tablet please visit www.ms2step.com.au